Live Breaking News & Updates on Singapore health sciences authority

Stay informed with the latest breaking news from Singapore health sciences authority on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Singapore health sciences authority and stay connected to the pulse of your community

Junshi Biosciences Announces NDA Acceptance in Hong Kong

SHANGHAI, China, April 24, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading...

Maryland , United-states , United-kingdom , Beijing , China , San-francisco , California , Suzhou , Jiangsu , Singapore , Malaysia , Hong-kong-special-administrative-region

Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab

Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

India , Malaysia , Suzhou , Jiangsu , China , Beijing , Singapore , Jordan , Australia , Hong-kong-special-administrative-region , Hong-kong-general- , Hong-kong

FDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer

FDA Approves Genentech's Alecensa as First Adjuvant Treatment for People With ALK-Positive Early-Stage Lung Cancer
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Singapore , Canada , United-states , South-san-francisco , California , Australia , Americans , American , Australian , Ken-culver , Levi-garraway

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Australia , Singapore , Maryland , United-states , Shanghai , China , Suzhou , Jiangsu , Peking , Beijing , Guangzhou , Guangdong

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer By Investing.com

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer By Investing.com
investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.

United-states , Beijing , China , Australia , Renji , Henan , Peking , Guangzhou , Guangdong , Shanghai , Singapore , San-francisco

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

Guangzhou , Guangdong , China , United-states , San-francisco , California , Suzhou , Jiangsu , Australia , Shanghai , Maryland , Beijing

Trastuzumab Deruxtecan Receives FDA Approval for HER2-Positive Solid Tumors

FDA granted accelerated approval to trastuzumab deruxtecan-nxki for adult patients with unresectable or metastatic HER2-positive solid tumors who received prior systemic treatment and have no satisfactory alternative treatment options.

Singapore , Canada , Brazil , Australia , Brazilian , Australian , Health-canada , Brazilian-health-regulatory-agency , Singapore-health-sciences-authority , Daiichi-sankyo-inc , Australian-therapeutic-goods-administration

Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023

/PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development,...

United-kingdom , Huashan , Henan , China , Taiwan , Beijing , Hong-kong , United-states , Singapore , South-korea , Shanghai , Macau

Osteopore granted regulatory approval for innovative bone reconstruction procedures in Singapore and Vietnam

Osteopore granted regulatory approval for innovative bone reconstruction procedures in Singapore and Vietnam
smallcaps.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from smallcaps.com.au Daily Mail and Mail on Sunday newspapers.

Vietnam , Republic-of , Singapore , Vietnam-department-of-medical-equipment , Singapore-health-sciences-authority , Health-sciences-authority , Medical-equipment , Asia-pacific ,

AI Medical Service Inc. Completes First Regulatory Review and Device Registration of Gastric AIbased Endoscopic Diagnosis Support System from Singapores HSA

AI MEDICAL SERVICE INC. hereinafter AIM a medical startup specializing in the development of diagnostic endoscopic AI is excited to announce the first instance of Singaporean regulatory review and device registration for an AIbased endoscopic diagnostic support device that operates within the stomach brand name Endoscopic image diagnosis support software gastroAImodel G.

Tokyo , Japan , Toshima-ku , Singapore , South-korea , Singaporean , Tada-tomohiro , Manami-taniguchi , Tomohiro-tada , Ai-medical-service , National-university-hospital-of-singapore , Singapore-health-sciences-authority